BDBM163056 US9062004, 21::US9670216, 21 2-(3,5-Bistrifluoromethylphenyl)-4-chloro-5-dimethylaminopyridazin-3-one

SMILES CN(C)c1cnn(-c2cc(cc(c2)C(F)(F)F)C(F)(F)F)c(=O)c1Cl

InChI Key InChIKey=GPSZUZRICRUDCZ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 163056   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163056(US9062004, 21 | US9670216, 21 2-(3,5-Bistrifluorom...)
Affinity DataIC50: >1.00E+4nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163056(US9062004, 21 | US9670216, 21 2-(3,5-Bistrifluorom...)
Affinity DataIC50: >1.00E+4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent